Envoy Medical Inc (COCH) Stock Price, Quote & News

Company Profile

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy...

Industry: Medical Devices

Sector: Healthcare

Phone: 877 900 3277

Website: www.envoymedical.com

Address:

4875 White Bear Parkway, White Bear Lake, United States

RedHottie Oct. 8 at 1:12 PM

$COCH

0 · Reply

Wintermelonjuice Oct. 8 at 1:09 PM

$COCH compare Envoy medical's cochlear device and Cochlear Ltd's cochlear device.

0 · Reply

OpenOutcrier Oct. 8 at 12:55 PM

$COCH (-37.1% pre) Envoy Medical raises $4 million in registered direct offering https://ooc.bz/l/79723

0 · Reply

Wintermelonjuice Oct. 8 at 12:53 PM

$COCH

1 · Reply

Popeye989 Oct. 8 at 12:53 PM

$COCH ouch. Why?

0 · Reply

Wintermelonjuice Oct. 8 at 12:52 PM

$COCH they are presenting on the 10th? They might reveal data on the first 10 pts. Must be surprisingly good to have gained FDA approval to proceed to final stage of phase 3 comprising of 46 pts this early.

0 · Reply

Wintermelonjuice Oct. 8 at 12:46 PM

$COCH Cochlear Limited was once a 3 AUD stock, now almost AUD 300 a share.

0 · Reply

Wintermelonjuice Oct. 8 at 12:43 PM

$COCH this is the world's first fully cochlear implant. How many patients in the world? A device costs around $20000-$35000., maybe more due to fully implantabke.

0 · Reply

Wintermelonjuice Oct. 8 at 12:41 PM

$COCH think Cochlear Limited might just buy out the company. They are doing share dilution to a point where there is no need for shareholders vote for warrants approval.

0 · Reply

Wintermelonjuice Oct. 8 at 12:36 PM

$COCH Cochlear Limited market cap is 18.942 billion dollars.

1 · Reply

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 7, 2025, 8:00 AM EDT - 1 day ago

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025, 8:00 AM EDT - 1 day ago

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 1, 2025, 8:00 AM EDT - 7 days ago

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Sep 25, 2025, 8:00 AM EDT - 13 days ago

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 24, 2025, 8:00 AM EDT - 14 days ago

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 22, 2025, 8:00 AM EDT - 16 days ago

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 19, 2025, 8:00 AM EDT - 19 days ago

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 10, 2025, 8:00 AM EDT - 4 weeks ago

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 9, 2025, 8:00 AM EDT - 4 weeks ago

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 8, 2025, 8:00 AM EDT - 4 weeks ago

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Sep 3, 2025, 8:00 AM EDT - 5 weeks ago

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Aug 26, 2025, 8:00 AM EDT - 6 weeks ago

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 20, 2025, 8:00 AM EDT - 7 weeks ago

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Jul 31, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Reports on Second Quarter 2025 Results

Jul 8, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Jul 1, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

Jun 26, 2025, 8:00 AM EDT - 3 months ago

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Jun 11, 2025, 8:30 AM EDT - 4 months ago

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Jun 10, 2025, 8:30 AM EDT - 4 months ago

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

May 13, 2025, 9:15 AM EDT - 5 months ago

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

May 1, 2025, 4:30 PM EDT - 5 months ago

Envoy Medical Reports on First Quarter 2025 Results

Apr 22, 2025, 6:00 AM EDT - 6 months ago

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Mar 31, 2025, 9:15 AM EDT - 6 months ago

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 9:25 AM EDT - 7 months ago

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Mar 12, 2025, 9:00 AM EDT - 7 months ago

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Mar 10, 2025, 9:00 AM EDT - 7 months ago

Envoy Medical to Participate in the 37th Annual ROTH Conference

Feb 24, 2025, 9:25 AM EST - 8 months ago

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Feb 14, 2025, 9:15 AM EST - 8 months ago

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Dec 19, 2024, 9:00 AM EST - 10 months ago

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Nov 14, 2024, 8:38 AM EST - 11 months ago

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Nov 12, 2024, 9:25 AM EST - 11 months ago

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Nov 8, 2024, 9:25 AM EST - 11 months ago

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical to Present at the LD Micro Main Event XVII

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Sep 12, 2024, 7:19 AM EDT - 1 year ago

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying

HYLN SXTP

Aug 12, 2024, 8:34 AM EDT - 1 year ago

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

Jul 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Announces Inclusion in the Russell Microcap Index

Jun 11, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling

Jun 6, 2024, 9:00 AM EDT - 1 year ago

Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index

May 19, 2024, 4:45 AM EDT - 1 year ago

Envoy Medical Is Pursuing Filling A Hearing Industry Void

May 15, 2024, 4:05 PM EDT - 1 year ago

Envoy Medical Reports First Quarter 2024 Results

Apr 3, 2024, 8:05 AM EDT - 1 year ago

Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

Apr 2, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 12, 2024, 10:52 AM EDT - 1 year ago

Envoy Medical to Participate in the 36th Annual ROTH Conference

Mar 4, 2024, 9:20 AM EST - 1 year ago

Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial

Feb 7, 2024, 9:00 AM EST - 1 year ago

Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

RedHottie Oct. 8 at 1:12 PM

$COCH

0 · Reply

Wintermelonjuice Oct. 8 at 1:09 PM

$COCH compare Envoy medical's cochlear device and Cochlear Ltd's cochlear device.

0 · Reply

OpenOutcrier Oct. 8 at 12:55 PM

$COCH (-37.1% pre) Envoy Medical raises $4 million in registered direct offering https://ooc.bz/l/79723

0 · Reply

Wintermelonjuice Oct. 8 at 12:53 PM

$COCH

1 · Reply

Popeye989 Oct. 8 at 12:53 PM

$COCH ouch. Why?

0 · Reply

Wintermelonjuice Oct. 8 at 12:52 PM

0 · Reply

Wintermelonjuice Oct. 8 at 12:46 PM

$COCH Cochlear Limited was once a 3 AUD stock, now almost AUD 300 a share.

0 · Reply

Wintermelonjuice Oct. 8 at 12:43 PM

$COCH this is the world's first fully cochlear implant. How many patients in the world? A device costs around $20000-$35000., maybe more due to fully implantabke.

0 · Reply

Wintermelonjuice Oct. 8 at 12:41 PM

$COCH think Cochlear Limited might just buy out the company. They are doing share dilution to a point where there is no need for shareholders vote for warrants approval.

0 · Reply

Wintermelonjuice Oct. 8 at 12:36 PM

$COCH Cochlear Limited market cap is 18.942 billion dollars.

1 · Reply

ninda13 Oct. 8 at 12:31 PM

$COCH it should recover to offering price at least today

0 · Reply

Trhays0620 Oct. 8 at 12:29 PM

$COCH I'm not emotional, I hit buy on this thinking it was technically and fundamentally reasonable. What did I miss?

1 · Reply

Wintermelonjuice Oct. 8 at 12:26 PM

$COCH 10 pts treated, another 46 pts to complete phase 3. Pretty much wrapped up.

0 · Reply

Goldwave9 Oct. 8 at 12:25 PM

$COCH down 23% by adding. But all I can tell is this… By the time I'm done with this I'll be up 25% -50% or more --zero doubt. All I have to do is keep my mind out of the way lol

0 · Reply

Wintermelonjuice Oct. 8 at 12:20 PM

$COCH much bigger than cancer market and the device is a breakthrough device.

1 · Reply

Wintermelonjuice Oct. 8 at 12:20 PM

$COCH multi billion dollars' market opportunity if approved. Just a million units of cochlear implants shipped out is 20 to 40 billion dollars in revenues.

1 · Reply

Muskvoice Oct. 8 at 12:15 PM

$COCH The updated timeline to commercialization and other improved efficiencies has allowed management to cut its anticipated capital needs by $10-$15 million.

0 · Reply

Wintermelonjuice Oct. 8 at 12:14 PM

$COCH cochlear implant is covered by medicare.

0 · Reply

AllHailTrump2024 Oct. 8 at 12:12 PM

$COCH Patience! Short cockroaches 🪳 playing games

0 · Reply

Yeueehehe Oct. 8 at 12:10 PM

$COCH offering at 1.33 and dropping to 0.98 😂😂😂

0 · Reply

jodirbrown6 Oct. 8 at 12:08 PM

$COCH holy smokes! When do you start averaging down?? This is crazy!!

1 · Reply

Wintermelonjuice Oct. 8 at 12:06 PM

$COCH massive amount of open short shares. These can't cover if good news comes out.

0 · Reply

Market Cap	19.21M
Revenue (ttm)	230,000.00
Net Income (ttm)	-20.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9,043.48%
Debt to Equity Ratio	-0.94

Volume	145,963,609
Avg Vol	3,338,026
Day's Range	N/A - N/A
Shares Out	23.81M
Stochastic %K	74%
Beta	2.09
Analysts	Strong Sell
Price Target	$7.33